Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q3 2022 · 10-Q
Revenue$597.86M$597.86M+77.9% vs Q3 2021 Net Income-$13.21M-$13.21MN/M vs Q3 2021 EPS Diluted-$0.55-$0.55N/M vs Q3 2021 Gross Profit$186,396,000+45.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,309,000−97.1% Free Cash Flowderived-$18,367,000N/M Margins · derivedGross margin31.2%−6.8 pt vs Q3 2021
Operating margin-0.1%−11.5 pt vs Q3 2021
Net margin-2.2%−11.5 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 7, 2022 · 38 d after period end